Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER

DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE

Standard Dose
5GM/100ML;32MG/100ML;128MG/100ML;234MG/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 017385 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 5GM/100ML;32MG/100ML;128MG/100ML;234MG/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-07-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 017385 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 5GM/100ML;32MG/100ML;128MG/100ML;234MG/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2018-07-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER (DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE) | Drug Monograph | MedicHelpline